Skip to main content

StemBond Technologies

The startup has developed a hydrogel tissue culture platform that utilizes physics-based methods to provide precise control over cell fate and function in three-dimensional environments. This technology enhances reproducibility in cell culture, facilitating advancements in tissue engineering and regenerative medicine for medical professionals.

Traction 3/10
Cambridge, United Kingdom · HQ
Founded 20217500+ followers
  • Biotechnology
Updated 6 months ago

Funding

Funding rounds are not available yet.

Founders

1 founder

Andrew Hodgson

CEO of StemBond Technologies

Product

Features

  • The startup has developed a hydrogel tissue culture platform that utilizes physics-based methods to provide precise control over cell fate and function in three-dimensional environments. This technology enhances reproducibility in cell culture, facilitating advancements in tissue engineering and regenerative medicine for medical professionals.
This profile is AI-generated and may contain inaccuracies.